Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lumdus, I agree with your last post. My e-mail to the C.E.O. was very strong and indicated that there were disgruntled investors that were disappointed that the only potential possible cancer curing compound was going to be placed in a new Company. Thus, the clarification. I am also pretty sure that they were thinking of the formation of a new company to develop and market any potential cancer curing compounds more than six months ago when they initially noted that they were no longer going to develop compounds in CSBR. The development and marketing of such compunds is simply too expensive and CSBR can no longer offer a big enough "piece of the pie" for new investors to be interested. I must wait for an announcement from CSBR detailing what the new arrangements will be, the percentage of the minority interest of CSBR in the new company and the percentage of the insiders of CSBR that has partial ownership in the new company. I am pretty sure that I may not be able to get the latter information. However, after saying this, I am still very bullish on the stock of CSBR. One thing that does get my attention is the purchase of 3,000,000 shares of CSBR by Battery Partners, only about a month ago, from the original shareholder. They bought these number of shares after they must have known about the new arrangement. I can not think of another reason that they would do this.
We must all wait until the deal is disclosed. Again, I repeat, that it is premature to make any investment decision as to whether the deal would be good or bad for CSBR. At this point based on everything that I currently know through the papers and through everything that I have seen regarding the chief executives getting stock compensation instead of cash compensation, I believe that this decision will be the best for the Company and for the shareholders since the motivation of management is to make it that way. These are very sharp people and businessmen that will be making this decision to sell them short, at this time, I believe would be a poor investment decision.
I respectfully disagree with you for Lumdus for the reasons that I mentioned in my previous messages.. I brought the situation to the attention of Joel Ackerman on the 16th of this month (Saturday)through an email and that is why there was a correction in what was stated in the Israeli newspaper. The Company will not give away any compound without getting something in return for it. As I mentioned, The Company six months ago decided not to in-license any more compunds since the cost to license these compounds and bring them to fruition is simply too much and involves an awful lot of capital. Money people are not willing to place their investments in CSBR for a small slice of the action of new drugs They would rather place it in a Company where they get a bigger slice of the pie. Bringing a compound through testing and marketing is a very expensive and risky business. I believe that CSBR is negotiaiting with Tevi Pharmaceutical, the largest pharmaceutical Company in Israel and one of the largest in the world, to obtain more drugs for its testing on the tumorgraft platform. This will increse the revenues in CSBR. At the same time, they will gain advantage of any cancer curing drug potentail that they discover through their supposed minority interest in the new Company as well as perhaps getting some sort of royalty or other revenue stream fromk these potential cancer curing drugs. I believe that the article mentioned that Sidransky is in Israel on a sabbatical. I believe that Sidransky may be in Israel to negotiate a deal with Tevi. This is the Company that acquired Cephelon with whom CSBR has a contract. For the time being, I believe that CSBR is doing the right thing by operating the Company as frugally as possible while at the same time taking advantage of any drug that it might discover that has good potential. Dr. Sidransky, besides being one of the finest oncologist and scientists in the world, is also a very shrewd business man. If you sell him short you do so at your own investment peril. I have been and still am bullish on CSBR until some strong evidence indicates that I should no longer take that stand. Again, Battery Partners just bought 3,000,000 shares of the Company about a month ago. I am certain that they do not like to throw aweay money. They know something that we do not and that will become apparent soon. For the time being, CSBR investors would be smart to wait for the outcome of Dr. Sidransky's negotiations. If anything, I would be a buyer of CSBR stock at this point. The incentive of management is obvious. Just about all of them have received stock compensation and not monetary compensationm. No person in his right mind would do that if he did not feel that the Comopany had some real good potential to make it big.
It is my opinion that CSBR has reached the conclusion that the development of cancer curing drugs and the further testing and marketing of these drugs on a joint venture basis is simply too expensive. So, except for the drug that they currently have, they are no longer going to in- licenese any more possible cancer curing drugs but instead they will receive a minority interest in a Company yet to be foremd in which they will send to that Company drugs that show promise for possibly helping to cure certain cancers. It is possible that they will joint venture with the Company or possibly receive a royalty from the new company as well as hold a minority interest in the new company. In this way they could avoid the huge expense in the licensing and developing of new drugs while, at the same time, obtain a financial interest through a minority interest in the new company. All of this still remains to be worked out and i feel it is simply too early to reach any conclusions as to the effect that this will have on CSBR on a cumulative basis when all things are considered. I believe that CSBR remains a strong investment ooportunity.
I guess that the email that I wrote to Joel Ackerman, C.E.O. of CSBR on July 16th, 2011 really worked. I brought the situation to his attention and he has clarified the story. The rest of his statement is consisitent with previous announcements as I had previously indicated. He did not say anything about any minority interest situations with a Company yet to be formed. I guess that, at this point, he does not want to go on record as saying anything about that situation until somewhere down the road. When the situation clarifies itself, I am certain that he will make an announcement.
Hi again Beaner:
I believe that every new potential drug product will have to pass through CSBR to determine whether the drug passes the test of our tumorgraft technology. If it does, then it will be passed on to the new Company. I should point out that there were several drugs that went through the tumorgraft platform that did not pass this test. However, CSBR got paid for the testing procedures on its tumorgraft platform. That is why, I believe, that this may be a net positive for CSBR. When CSBR was going to set up a library of potential cancer curing drugs it had to pay for the rights up front and then if the drug did not draw muster, it lost money on it. I repeat, I believe that this could be a positive for CSBR by increasing substantially its tumorgraft testing procedures on thes drugs and thus increasing CSBR's revenues. It also gives CSBR the opportunity through increased successful usage of its platform that it should gain interest of other biotechnology and pharmacy companies in using that platform. I would not make a decision as to whether or not this is a good or bad thing for CSBR until I had additional information.
Hi Beaner:
There are too many unknowns. however, it seems to me that CSBR will have to make an announcement regarding the Company since the minority interest must be reflected in the next 10-K if the Company is funded. Also, we do not know when the rights for the drug that was being tested was being transferred to the new Company. This must also be diusclosed. I, too, am concerned about the lack of disclosure and that is why i wrote the email to the C.E.O. that an announcement had to be made soon or CSBR runs the risk of current shareholders selling their stock due to a lack of information and assumptions that they are making that may be wrong.
There may be a positive spin on this in that CSBR may increase the number of drugs going through the tumorgraft platform to determine whether the drugs have any eficacy in treating cancers. This may lead to a significant increase in sales of CSBR. Perhaps management wanted to become the Company that tests all of the potential drugs for the Israeli Company.
At this point, there are simply too many unanswered questions for us to make a valid decision as to whether this will turn out to be a positive for CSBR. I specifically asked the C.E.O. to indicate why CSBR shareholders will be better off with this kind of a set-up than they would have been the other way. It could be that CSBR felt that they could not get investors who would invest sufficient funds in CSBR to take the drugs through the testing procedures since they would not get a large enough percentage of the Company for the risk that they would be taking. I suspect that pretty soon there will be full disclosure as to exactly what is going on particularly since I let the "cat out of the bag" by letting management know that we investors are aware of what is going on in Israel with CSBR but do not know the details.
This is still a little confusing to me except that Teva is involved and that may pass on additional business for CSBR. I believe that CSBR found that drug development is simply too expensive and is using this course of action as a means of increasing revenues in CSBR as well as getting a piece of the action of drug development through a minority stake in the new Company. Still, we must have some PR announcement from management to determine exactly what is going on and the benefit that this would inure to CSBR shareholders as compared with joint ventures and royalty agreements under the old method. I believe that Sidransky has found that this method will be more lucrative for CSBR shareholders. Is the new Company a public Company for which we can buy shares? Any new thoughts on this Beamer or Milburn and thanks for your inputs.
Hi beaner:
We are assuming that Dr. Sidransky will have a personal stake in the new Company along with the C.E.O. and the president of CSBR. I think that , at this point, that is a huge assumption. Of course, we must also assume that Battery is involved in this in some way. Is this subsidiary going public or is it a private company? I still would love to see this article in english. Again, I repeat that for some time, CSBR literature has stated that they are getting out of the drug marketing and joint venture business. Take a look at their website. This is not new. Of course, what is new is that they are perhaps setting up a new Company to develop drug products and that new company will be partially owned by CSBR as a minority stake. What kind of minority stake are we talking about. I still believe that we must give management a chance to explain exactly what is going on. When will the new Company be formed and who will be funding it? there must be disclosure for SEC purposes to avoid apparent conflict of interest. If what you say is true, the management of CSBR may be treading on very thin ice. As yet, I have not seen anything that says that CSBR is transferring this valuable asset to another Company for a minority stake in that Company.
Incidentally, Beaner, my email to Joel Ackerman was very strong indicating that management must come up with an announcement so that there will be no wrong assumptions as to the motivation of management. It was a lengthy email and I am hoping for some sort of a response. In the meantime, I will keep an open mind and assume that this move that CSBR intends to make is a positive for current shareholders in the long run. I am not being naiive on this matter. Rather, I am assuming that management would not do something so stupid as to hurt their current investors including the institutional investors since they will need money in the future. It is incumbent on us, as investors, to continue to find out more about this potential Company. Can you please refer me to the article in english that shows the information. I only saw the article in hebrew. Thanks.
I am not certain as to your analysis. For some time, CSBR has indicated that it was getting out of the joint venturing on possible new drugs that may hel;p cure cancer. I agree that the big bang in this Company was the new drug potential and partnerting with Companies that would make this happen.. There is a significant investment by an institutioanal investor (about 12 million dollars) and there is the purchase of an additional 3,000,00 shares by this institutional invetor from the original shareholder just a few weks ago. Obviously they know something that we do not know. In addition, it would be in the best interests of the president and CEO to make the stock of CSBR move upward because of their CSBR stock positions unless they will also own shares in the other Company. I do not think that any assumptions can be made here as to what the motivation of managment is without hearing from management. I believe that it would be premature to make those assumptions. As I mentioned in my previous comments, I sent an email to the C.E.O. for clarification which I believe that they will have to make in order to avoid false assumptions.
I am also at a loss to explain why management would not want to eventually be taken over. the Tumorgraft platform is very good. However, it can go so far in its ability to turn it into the golden pot at the end of the rainbow. I believe that Sidransky would eventually want to sell out and continue his consultations with a larger company. After all, he does have 11,000,00 shares in CSBR and he certainly would want to cvash that in at some point. Dr. Sidransky, from all that I can see, is a very savvy business man and i believe that he has some good motivation to do this. Incidentally, the institutional investors that invested in the Company knew that CSBR was going to downplay the future of joint ventures in drugs and still invested about 12 million dollars in the CSBR.
One could make assumptions that Sidransky will be a secret partner in the new Company along with the C.E.O. and President. However, I believe that assumption has yet to be proven and may be considered mismanagement and asset conversion.
As I said above, I believe that we must wait and not draw any possible eroneous conclusions as to what the motivation of management is regarding this matter. As you said in your email, there is much that we do not know and that hopefully management would make clear. I believe that an email from investors, other than myself, to management would help show the concern that all of us have in this matter. I absolutely agree with you on this matter that discloure is a must and I made that perfectly clear in my email to management.
Incidentally, I feel that there must be disclosure of any stake that CSBR has in another Company according to SEC rules. If they have a minority ownership in another Company that ownership would have to be reported in the financial statements. Again we know too little to make an informed decisipn, at this point, as to what is truly going on here.
Hi again Beaner:
I have just written an email to Joel Ackerman, C.E.O. asking him to explain why it is necessary to set up a separate subsidiary for the development of new drugs and have CSBR take only a minority interest in that subsidiary when they could probably raise the funds themselves for that subsidiary and take a majority ownership in that subsidiary. I told him that there are disgruntled investors that need an explanation as to why this is necessary. I will inform you of his response when it arriives.
Hi again Beaner:
I have just written an email to Joel Ackerman, C.E.O. asking him to explain why it is necessary to set up a separate subsidiary for the development of new drugs and have CSBR take only a minority interest in that subsidiary when they could probably raise the funds themselves for that subsidiary and take a majority ownership in that subsidiary. I told him that there are disgruntled investors that need an explanation as to why this is necessary. I will inform you of his response when it arriives.
Hi Beaner:
CSBR has indicated some time ago that it was no longer pursuing new drugs on a pertnership basis and that it was sticking to its tumorgraft technology. Apparently, they have spent too much money in trying to get new drugs started with the investments that they have made and they want to get out of that field. I do not know what minority interest that they will have in the development of these new drugs. We will have to wait and see on that one. I believe that there is a very large biotechnology company in Israel that just bought one of the Companies with whom CSBR does business. I believe that the name of that Company is Tevya and perhaps they are the ones that will be supplying the money.
It has long been my theory that CSBR will get their tumorgraft technology to a certain point and then will sell the Company. One of the interesting occurences this past year is that the original shareholder sold 3,000,000 shares of his stock to an instituitional investor. Obviously there is great interest by that institutional investor in CSBR. In addition, the President and C.E.O./Treasurer have been paid with stock as their compensation. This is an excellent way of preserving cash on the one hand and motivating management to move the stock on the other hand. It would appear to me that executives of this caliber would have to be crazy to accept an all stock compensation program if they thought that CSBR did not have a great future. In addition, I believe that it was the C.E.O. who got the institutional investors to invest.
If you eliminate the stock based compensation, CSBR lost only 0.02 this last fiscal year ended April 30, 2011 on a non-gap basis. This is a stellar performance.
I must say that I need to know more about this possible spinoff that is being planned before I can make a judgement call as to whether this is good or bad for the Company. It seems to me that CSBR is in an excellent position to determine whether a potential cancer drug has any potential to be successful through its tumorgraft technology. If so, they could then pass it on to the new spin off Company for the payment of a royalty.
Dr. Sidransky is excellent in preserving cash and in incentivising executive personnell through the issuance of stock rather than payiong them cash. One should note that CSBR has no debt to banks on its balance sheet and that it has done all of its growth through private placement of the Company stock. In addition, he has not replaced the previous Treasurer, but instead hires him out on a consulting basis to do the reporting required to the federal government such as the 10K. Once again, ,Sidransky clearly understanda the importance of maintaining cash in the Company while at the same time incentivising his employees through stock compensation.
I am a little upset over the lack of announcements as to developments in the Company. However, because of stock agreements previously made to institutional investors, I believe that Dr. Sidransky created a base below which this stock will not go for at least the short term. We must await further developments and announcements by the Comopany as to where exactly it is headed with this possible spinoff. Perhaps a letter to the C.E.O. would help obtain this information. Obviously, the Board knows what is going on, I will try to bring some pressure on Joel Ackerman through an email to make an announcement as to the details of this proposed spinoff and to let him know that some of the investors in CSBR are aware of it.
I believe that CSBR stock will soar upward over the next four days. My reasonng for this belief is as follows:
1. On June 21, 2011, Battery Partners IX LLC purchased 3,000,000 shares of the Company's stock from James Martell, the previous President of CSBR.
2. Bewtween April 27 and April 29,2011 the stock of CSBR moved up approximately 22% and between May 24 and May 31, 2011, the stock of CSBR moved up about 22%. This is called institutional window dressing.
3. CSBR will soon issue its certified financial statements for the year ended April 30, 2011. These financial statements are due sometime in July, 2011 and I believe that it will show a significant increase in all categories of income over the previous fiscal year.
To my fellow investors, I say enjoy the ride up. To potentially new investors, I believe that the time to buy is right now, TODAY.
Hi Beaner. I do not understand your post. There has just been a 9.4 million dollar investment in CSBR which is eseentailly iliquid until there is a filing with the SEC. Again, I will repeat myself. The volume is not, in any way, high volume when compared with other companies. I have said that over and over again. However, it is high volume when compared with the history of CSBR, particularly recent history. Just go back over the volume amounts over the past year and I believe that you will find only one or two periods of 3 day volume that is the same or surpases the current volume. I have a theory about the trading of shares in CSBR. However, i will have to see the volume of trading during the upcoming months to see whether I am correct. If so, I will explain my theory at some future point.
No, I would not consider 69,000 shares huge volume. What I said is that it is historically, for CSBR, huge volume. If you go back to take a look at its previous volume days you will notice that for CSBR this is high volume. In addition, because of the small float, days like this could magnify the increase. Peculiar things happen in this stock in which there is high volume. I wonder what would happen to this stock if there were seven straight days of volume of 70,000 shares or more, which for most stocks is low volume but for CSBR is high volume.
I would agree with you except for the fact that price swings with huge volumes do mean something. We have had historically high volume of shares traded for this stock in the past two days and yesterday all of the trades seem to have gone through on the asked side. To me, on an historical basis, with this stock, that is very meaningful. Should this stock break through $1.20 on substantail volume, that would also be very significant. In addition, what is also significant is the amount of positive news coming from management and the greater amount of potential investors that are learning about CSBR. I do believe that there has been a definite change in the movement of the Company stock. There will always be investors that sell at market and the MM boys who will gobble them up at a rediculous price. The idiot that sold a short while ago for 0.45 must have put in a market order and obviously he did not do his due diligence. For a long time, this stock was undervalued languishing in apparent anonimty. I believe that in the past few days it has come out of its shell and, like a new debutante, is being presented to a whole new class of invetors who seem to like the "beauty" of the Company. Remember that $4.00 is management's immediate goal to get listing on the NASDAQ. We will have to see what today brings.
As I was saying, I am tremendously bullish on CSBR which went up about 25% today. This is definitely a reflection on all of the good news that has recently been announced. Technically, this stock is in a phenomenal bullish mode and a move above $1.20 will propel this stock much higher. It should be noted that all of the trades were on the asked side which means buyers were buying and holders were not selling on the bid. Fundamentally and technically this stock is in its early stages of movement. Remember that the stock must stay in the $4.00 range for a period of time in order for it to be listed on NASDAQ. I believe that it will get there in the not too distant future. Good luck and good fortune for all of those who took my advice to buy this stock and for those who did not, it is not too late. BUY NOW.
Hi CHM. I issued my bullish projections on yahoo-finance a few days ago and I have been actively posting to the Cephelon Message Board telling them about CSBR. I am bullish long and short-term. This stock has moved up 40% in three or four days. From a technical standpoint it has plowed through its 50 day and 200 day moving trendline, has made a new high and is in the process of finishing a W formation. This is wildly bullish. I can not see why anyone would sell this stock at this point, particularly if they are long-term investors, except for the possibility of profit taking. Actually, today's move even caught me by surprise. However, if you look at the past history of this stock when it moves up, particularly when it makes new highs, it goes even higher. With such a small float, it is no wonder that this stock is soaring. Now is the time to buy and not to sell except for special circumstances.
I just saw a significant announcement made by CSBR on Friday regarding the licensing of IRONPHORE C from the BC Cancer agency in British Columbia, Canada. The reason for the licensing was the positive results obtained from the Tumorgraft study of the compound. Phase 1 clinical studies are to begin in the fourth quarter of 2011. This compound is to be used for patients having advanced solid tumors. I believe that this is the first compound that was licensed that is going into Phase 1 Clinical study. It seems to me that this announcement is of great significance to the Company in that it is a direct indication what the Tumorgraft Platform can do for the Company in getting the Company involved with a compound that could directly help advanced cancer patients.
Interesting day of trading. Initially the stock ran to $1.09 and then apparently profit taking took place and took the stock back down to 0.85. Then there was buying that brought the stock back to 0.95. I hope that those who did the profit-taking also did their due diligence. There are simply too many positive stories, including the licensing by CSBR of one of the drugs it had been testing, to have sold this stock at this time. If people who werre sellers of this stock felt that it was a pump and dump they are absloutely wrong. On the other hand, I could see some people taking profit on a portion of their positions if they have been in csbr stock for some time. I was not a seller of the stock today since I feel that it will continue to go up in the near future (perhaps even tomorrow)because of the positive stories that have been circulating. I am indeed a long term investor and am very bullish over the short and long-term. I believe that investors do themselves and injustice if they get out of the stock now.
Hi Milburn:
Thank you for your compliment. One other thing that I did not mention before. It should be noted that this Company has very little debt (mainly accounts payable) and it pays its executives with stock. Therefore, the success and motivation of these executives are directly tied into the performance of the stock. I do think that Dr. Sidransky has done a wonderful job. However, there is definitely a lack of communication in getting the word out. I leave that up to the President and C.E.O. and I believe that you will see the stock move up in the very near future as soon as more and more people realize what a good investment this is.
Thanks Milburn. That is good news. The pink sheets simply have a very bad stigma attached to it. This news slong with the good financials and the Cephelon deal as well as the conference in Orlando where Dr. Sidransky is making a presentation bodes well for this stock next week. I certainly would not be a seller of this stock at this point particularly because it has broken out of its trading range and has crossed both the 50 and 200 day moving averages, a very bullish sign. Now, if only management would make the announcement of the fact that they are off the pink sheets it should help the stock move even higher.
This was an interesting run up today. It ran up on minimal shares. Apparently, I am looking at this Copmpany a little bit different that you fellows are. I have had conversations with the current C.E.O. and the the two past presidents, including Martell. Their main interest is to get these shares up to $4.00+ per share so that they can get listed. I agree with you, to some extent, that it looks as though they are using this stock as there own piggy bank. However, they are moving forward quickly and their last financial statements showed a NON-GAAP profit. I believe that it will be in their best interest (especially the C.E.O.) to not let this stock go below $0.75 per share. I have absolute faith in Dr. Sidransky to get the job done. I just found out that he will be a half hour away from where I live this weekend and I am trying to get a meeting with him. However, I do not think that I will be able to do it since I found out too late that the Conference that he will be attending is here. I am of a firm mind that this Company will be sold before it gets too big. I have always ,and I continue to say, that the sales price would be $10.00 per share. I am very happy to move along on the coat tails of the "piggy bankers" and hope that they will make multi- millions of dollars. The rise in this stock was very interesting and showed what a small float will do. Soon, we will have new investors in this Company and I suspect that they will test the small float and move the stock upward. However, in the final analysis, it all gets down to Dr. Sidransky as it has from the very beginning and I totally believe in his skill to move this Company forward so that all will prosper.
Perhaps an omen for the future. The current bid on CSBR stock is $0.45 per share and the current ask is $10.01. However, do not count your money yet since I think it must be a typo. But, it is nice to dream isn't it?
Thanks Beaner. I already had read it. Well, this solves any problem they may have had with cash flow, but seems to price CSBR at 0.75 per share, which is a reduction of 0.09 per share from its current level. I laugh at this for a moment since one of their first private placements that they made a few years ago was at $1.75 per share when the Company had practically nothing. Now, several years later, when the Company has its best financial statements as well as a good contract with Cephalon , the Private Placement is at $1.00 per share cheaper than it was when it had nothing but a future and no financials to it up. Perhaps the price has been kept artificially low by the new C.E.O and new President so that they and their fellow investors would be able to buy in at such a lucrative price. There will be a presentation at AACR on April 5, 2011. Perhaps, at that point, the stock will begin to move up. The one positive thing is that CSBR has grown the Company through equity capital rather than through debt. However, the valuation of the Company for the old investors has been way too low on an historical basis. The mere announcement of Dr. Sidransky as the Chairman of the Board four years ago caused the stock of CSBR to rise to $2.15 per share when the Company had nothing. We have come a long way since then. However, the stock has gone in the reverse direction. I believe that this Private Placement satisfies the requirement that the C.E.O and President raise at least $5,000,000 in Private Placement by April, 2011. Perhaps this will be the starting point for the movement upward. In addition, it is possible that the new investors will maintain the price of the stock of CSBR above 0.75 per share. I believe that they got a very sweet deal. The payoff for them, as for all of us, will come when CSBR is purchased by another Company which I am certain will happen someday.
On March 22, 2011 Cephalon announced a merger agreement with Gemin X, A Private Biopharmaceutical Company who is into research regarding oncology drugs. The price was $225 million. I present thid since it would appear that should CSBR be successful in its tumorgraft platform analysis with Cephalon, there is the possibility of a buyout. I have long felt that CSBR would be purchased by another company as it gains success in its tumorgraft platform and as its finanancial statements continues to improve. In addition, I have read some time ago that Carl Ichan was friendly with Dr. Sidransky and liked his work. I am not, in any way, spreading any false rumors, but merely presenting information which should make one very bullish on this stock and that is further reason that the price of $0.85 per share is absurd at this point. In addition, I have said in some of my previous posts that I felt that CSBR would be bought out at $10.00 per share. I will continue to be a buyer of CSBR as long as its stock price shows improvement.
I don't think so Beaner. However, when the stock went down to .60, I contacted the C.E.O. by email and informed him of the sale. I also told him that, from an investor standpoint, considering all of the positive information in the past week, the price of .60 per share was unacceptable. I then went in and bought 100 shares of CSBR at 0.84 per share and at 2:10 P.M. someone bought 7,500 shares at 0.84 per share. I remain proactive. This is what I have done today for our stock. I ask the rest of the investors what have you done today to maintain the value of CSBR stock?
Exactly what I thought would happen has happend. The stock has sold off to 0.60 per share and with no buyers apparently on the horizon this stock could continue to go down. Of course, this should never happen and I must blame current management for the position that the Company finds itself. You can not continue to take an attitude like current management is taking and expect this stock to do something. The new CEO and President should have long ago established value in the Company.
Hi Imcloner. Yes, I did purchase the 100 shares yesterday and I will continue to buy 100 to 500 share lots when I feel the time is ripe. I do not wish to disclose my total holdings, but to me, considering the speculative nature of the stock that I am in, it is substantial. I will continue to purchase shares of CSBR as soon as I see it really begin to move and am convinced that management has its act together. On the other hand, I am also thinking of reducing my holdings if I do not soon see positive action in the rise of the share price of stock
Hi Imcloner:
My expectations for CSBR have always been high for this stock because of Dr. Sidransky. He has performed very well. However, his subordinates have not. Since I have been in it from the inception (about 4 years), I certainly expected much more at this point and I believe so did the original management. My problem is reflected in the share price. On February 22, 2011 the price of these shares were 0.85 per share. Now, a little more than one month later, after announcing one of the best financial results, if not the best, in their history and after a significant contract with one of the leading Biopharmaceutical Companies in this world, their stock is 0.80 per share. That is simply unacceptable, particularly since the C.E.O. and President were brought in to increase the price of the stock. Is this not in and of itself a measure of poor management on the part of the CEO and President? If it is not, I do not know what is. I would assume tht Dr. Sidransky is very upset with this kind of performance. I also allude to my previous comment where the C.E.O was supposed to bring in $5,000,000 of capitalization by January 31, 2011 and in the footnote to the financial statements as of October 31, 2010 it looked like it was a done deal. However, it did not happen. Now, this capitalization is supposed to come by April 30, 2011. We will have to wait and see whether it would materialize. I am now a little too old (71 years of age). However, I wish that I had an opportunity to become the C.F.O. of this Company. I have had experinece before being the Treaurer of a stcok exchange Corporation and during my reign the stock ran from $3 to $10 per share. That was about 41 years ago. I was proactive then in anything I did. Now, I am lucky to be just a little active in anything I do. However, I still own my CPA practice after 40 years. I am not trying, in any way, to brag. I am just trying to analyze the suituiation the way I see it and I see a Company with phenomenol potential, if Dr. Sidransky can get his management team to perform that which they were brought in to do. Incidentally, they still have not hired a CFO and the quarterly financial statements and year end financial statements are due April 30, 2011, I believe.
Hi Beaner:
But that is the problem. There should be a market. I have been following a small company on the pink sheets which is dealing with solar panels. they have no sales as yet. However, they have potential. Their stock ran from 0.69 to $1.20 in a non pump and dump situation during the time that csbr went from .90 to .80. That simply is a case that CSBR management is not telling the story where the story must be told and the other Company is. CSBR is here and now. I maintain that this stock should be valued much higher than it is now and management must be proactive in making that happen. In addition, the new CFO is being compensated with stock for obtaining certain milestones. He was supposed to reach the milestone of a $5,000,000 private placement investment into the Company by January, 2011. Now we are told that it will take place in April. His incentive is incredible. However, his obvious production as far as the stock price is concerned is simply not there so far. I originally thought when he was appointed CEO of the Company that he had sufficient contacts in the investment world to move this stock up. That is one of the reasons that Dr. Sidransky hired him. We are still waiting for results. So far today only 2,500 shares have traded. On this kind of an announcement5 that is not, in any way, good results.
Correction to my previous email. I talked with the person who was President about 3 to 4 years ago, I believe that his name is Mr. Martinelli.
Beaner:
There is a big difference between pumping a stock and getting the stock to fair value. A perfect example of that is chk on the big board. That is, of course, a little different situation. I have been a holder of this stock since inception. I have seen this stock go to $2.15 per share and 0.45 per share this past Tuesday.
Long-Term is in the mind of the beholder. I am 71 so long-term to me could be a month or a year or if really lucky a decade. However, that is besdies the point. The point is that this stock is undervalued now in relationship to its past history and efforts should be made to get the word out. It is in its best position in its history financially and marketing wise and as of 2 days ago the worst position that it has been in the stock. I talked to the CEO a few days ago and he asked me what would be the best way to get the word out. That is an absurdity. He should know and not have to ask. The value of a Company is in the capabilities of its management. I have talked with the previous CFO and he did nt seem that he would leave such a well paying job unless there were some problems. They still have not chosen a replacement CFO. That should be done as soon as possible. I am a CPA. I have worked for 2 of the largest CPA firms in the world and have been in business for myself for over 40 years as a CPA. I was a Treasurer of a stock exchange listed corporation and am very knowledgeable of what it takes to make a Company successful for its shareholders. This stock is undervalued right now. There is very little activity in the stock and considering its performance over the last several months there should be a hightened amount of activity. Look at the share volumes in the past and you will see an awful lot of activity in a period of time when the financials and hopes of the Company was not nearly this good. I continue to believe, based upon my experience which spans 50 years, that this Company is undervalued and that management is not doing a good job in getting the word out. I asked the CEO why he did not have a PR firm and he said that the last one did not do a good job and that they are too expensive. I am sure that there is a decent PR firm out there that they could help and the cost would definitely be worth it to the Company.One more thing. What would happen if someone sells 20,000 shares of the stock at 0.45 per share now as they did a few days ago. How will the stock recoup.there are no other stories I do niot thinkl that would get the stock up. Patinece is fine in the right situation. In this situation, management must do something positive now especially since it is on the pink sheets and that is not something investors in small ciompanies like to see So, I am not after Pumping and Dumping. I am after a good value for the Company based on its current performance and that is not happening. At this rate, it will be a long time before they will be able to be listed on the NASDAQ. I talked with the Past President of this Company last year and he said that its goal was to be listed as soon as possible. He thought that it would be sometime this year. Managenment must move so that this Company will be abhle to reach its true potential for the shareholders. I have been the Company's biggest cheerleader. Go to yahoo-finance and you will see all of the messages that i have written since the Company was formed.
Yes CHM I did buy some more shares today. The financial results of this Company for the past quarter were simply great. The contract that they just signed with Cephalon was simply fantastic. The PR of the Company is awful. They should be yelling from the highest mountain about the Company and yet they are silent. Even the annoncement today was couched in a filing with the SEC. They should have made a much bigger deal out of this annonucement. You can rest assure that if i were an officer of this Company, the stock would not be languishiong where it is but would be upwards of $1.50. I have had previous experiencde being the Treasurer of an AMEX listed Corporation. I constantly write to the CEO, but am no longer getting any responses. If anyone knows the email of David Sedransky, please let me know so that I can drop him a line. This is a fabuulous Company that no one seems to know about. I think that we can form a PR Company of our own to represent only CSBR and do a better job than is being done currently by management.
Hi again Beaner:
The CEO told me that they are quoted on the pink sheets because they were one of 1,000 Companies that lost their status on the OB classification because it was too expensive for them to carry these Companies without a substantial market maker and apparently CSBR could not find one. I am absolutely flabbergasted that a Company like CSBR with one of their best financial reports is still languishing and worst. IT SIMPLY MAKES NO SENSE. They must get this stock to $4.00 per share for an elongated period of time so that they can be listed on the NASDAQ. This Company needs a good PR Company and I feel the shares would soar if they had one.
Hi Beaner. Cephalon is a major Biopharmaceutical Company with sales approximating $3,000,000,000 per year. This is a very significant occurence. I am still wondering why CSBR did not announce this on March 16, 2011 when the deal was reached. This should propel the stock up considerably. However, it is starting from a very low position at 0.45 per share. Incidentally, the news was only announced through the issuance of an 8-K and does not show up in the news section of the CSBR website.
THIS BLOWS MY MIND. There is a significant news story that apparently has not hit the wires regarding CSBR. Apparantly they have signed a significant comtract with Cephalon in which they will receive more than 1.5 million dollars by April 11, 2011 and a significant amount later. This story does not appear anywhere except on the Champions Biotechnology web site. Where is management on this? It should have been reported all over the news media. The stock fell to 0.45 per share today when someone sold a little more than 20,000 shares, at the bid price at 3:55 P.M. This should have never happened. I do not understand why management did not make a big splah out of this story. They simply are doing a horrible job in PR and in supporting the value and price of this stock. I was a Treasurer of an AMEX listed Corporation and a story like this would have been all over the news if I were the CFO of CSBR. I have written the C.E.O. asking for an explanation. After you read the article, I am sure that you will agree that now is the time to buy thios stock and not to sell it.
I believe that the pink sheet situation is only temporary. If one is on the pink sheest there is no necessity to file with the S.E.C. on a quarterly basis. The Company is continuing to do that filing. Therefore, I believe that it is more about the price of the stock than anything else. I am investigating further.